Curaleaf Holdings Inc.(CURA.TO)— 同类公司组

数据截至2026-09-18 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Curaleaf Holdings Inc.的Closelook综合评分为31/100,在同类公司组内排名第12位(共12家)——组内评分最高的是BB Biotech AG(74/100)。

名称综合动量质量估值信号距52周高点
CURA.TO Curaleaf Holdings Inc.31652226
ROVI.MC Laboratorios Farmaceuticos ROVI60207651info32.3%
LNTH Lantheus Holdings Inc60697558info10.1%
KNSA Kiniksa Pharmaceuticals Ltd56925819ok6.9%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895742ok2.9%
BHC.TO Bausch Health Companies Inc54507083info28.5%
ALKS Alkermes Plc53665222info22.1%
APTX.TO Apotex Health Corp48595648
BION.SW BB Biotech AG74749681info8.2%
DXCM DexCom Inc66868035bull5%
ARGX.BR Argen-X65797528ok5.8%
ARGX argenx NV ADR64797427ok7.7%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板

FAQ · from the current data · as of 2026-09-18

Quick answers

Curaleaf Holdings Inc.在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Bausch Health Companies Inc (BHC.TO)、Alkermes Plc (ALKS)、Apotex Health Corp (APTX.TO)、BB Biotech AG (BION.SW)等。

CURA.TO相对同类公司的评分如何?

Curaleaf Holdings Inc.的综合评分为31/100,组内排名第12位(共12家),截至2026-09-18;组内最高综合评分为BB Biotech AG(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.